Pandemic vaccination strategies and influenza severe outcomes during the influenza A(H1N1)pdm09 pandemic and the post-pandemic influenza season: the Nordic experience

Euro Surveill. 2016 Apr 21;21(16). doi: 10.2807/1560-7917.ES.2016.21.16.30208.

Abstract

During the 2009/10 influenza A(H1N1)pdm09 pandemic, the five Nordic countries adopted different approaches to pandemic vaccination. We compared pandemic vaccination strategies and severe influenza outcomes, in seasons 2009/10 and 2010/11 in these countries with similar influenza surveillance systems. We calculated the cumulative pandemic vaccination coverage in 2009/10 and cumulative incidence rates of laboratory confirmed A(H1N1)pdm09 infections, intensive care unit (ICU) admissions and deaths in 2009/10 and 2010/11. We estimated incidence risk ratios (IRR) in a Poisson regression model to compare those indicators between Denmark and the other countries. The vaccination coverage was lower in Denmark (6.1%) compared with Finland (48.2%), Iceland (44.1%), Norway (41.3%) and Sweden (60.0%). In 2009/10 Denmark had a similar cumulative incidence of A(H1N1)pdm09 ICU admissions and deaths compared with the other countries. In 2010/11 Denmark had a significantly higher cumulative incidence of A(H1N1)pdm09 ICU admissions (IRR: 2.4; 95% confidence interval (CI): 1.9-3.0) and deaths (IRR: 8.3; 95% CI: 5.1-13.5). Compared with Denmark, the other countries had higher pandemic vaccination coverage and experienced less A(H1N1)pdm09-related severe outcomes in 2010/11. Pandemic vaccination may have had an impact on severe influenza outcomes in the post-pandemic season. Surveillance of severe outcomes may be used to compare the impact of influenza between seasons and support different vaccination strategies.

Keywords: Pandemics; influenza A(H1N1)pdm09; influenza A(H3N2); influenza B virus; influenza virus; intensive care units; vaccines and immunisation.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Child
  • Child, Preschool
  • Female
  • Hospitalization / statistics & numerical data
  • Humans
  • Infant
  • Influenza A Virus, H1N1 Subtype*
  • Influenza Vaccines / therapeutic use
  • Influenza, Human / mortality*
  • Influenza, Human / prevention & control*
  • Influenza, Human / virology
  • Intensive Care Units / statistics & numerical data
  • Male
  • Mass Vaccination / methods
  • Mass Vaccination / mortality
  • Mass Vaccination / statistics & numerical data*
  • Middle Aged
  • Pandemics / prevention & control*
  • Pandemics / statistics & numerical data*
  • Pregnancy
  • Prevalence
  • Risk Factors
  • Scandinavian and Nordic Countries / epidemiology
  • Seasons
  • Severity of Illness Index
  • Survival Rate
  • Treatment Outcome
  • Young Adult

Substances

  • Influenza Vaccines